Eterna Therapeutics
ERNA
#10413
Rank
โ‚น1.33 B
Marketcap
โ‚น1,147
Share price
-3.77%
Change (1 day)
290.29%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): -โ‚น6,436

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น7,340. In 2022 the company made an earnings per share (EPS) of -โ‚น12,041 an increase over its 2021 EPS that were of -โ‚น79,553.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น6,436
2022-โ‚น12,041-84.86%
2021-โ‚น79,553

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น244.91-103.34%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚น203.80-97.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-โ‚น193.27-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น12.44-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น131.08-101.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
โ‚น67.93-100.93%๐Ÿ‡บ๐Ÿ‡ธ USA